Moxifloxacin EP impurity A

moxifloxacin hydrochloride impurity-a(ep)(usprc a) ; 1-cyclopropyl-6,8-difluoro-7-((4as,7as)-hexahydro-1h-pyrrolo-[3,4-b]pyridin-6(2h)-yl)-4-oxo-1,4-d ; moxifloxacin imp. a (ep,bp) ; 1-cyclopropyl-6,8-difluoro-7-[(4as,7as)-octahydro-6h-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ; 8-desmethoxy-8-fluoro moxifloxacin ; moxifloxacin related matter 1 ; 6h-pyrrolo[3,4-b]pyridine, 3-quinolinecarboxylic acid deriv. ; 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4as,7as)-octahydro-6h-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid ; moxifloxacin related substance a ; 3-quinolinecarboxylicacid,1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4as,7as)-octahydro-6h-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo- ; moxifloxacin ep impurity a ; moxifloxacin related compound a ; 3-quinolinecarboxylicacid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6h-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-,(4as-cis)-